Nicoll A, Coulombier D
European Centre for Disease Prevention and Control, Stockholm, Sweden.
Euro Surveill. 2009 Jul 23;14(29):19279. doi: 10.2807/ese.14.29.19279-en.
Europe has experienced more than two months of the first transmissions and outbreak of the 2009 pandemic of A(H1N1)v. This article summarises some of the experience to date and looks towards the expected autumn increases of influenza activity that will affect every country. To date the distribution of transmission has been highly heterogenous between and within countries, with one country the United Kingdom (UK) experiencing the most cases and the highest transmission rates. Most infections are mild but there are steadily increasing numbers of people needing hospital care and more deaths are being reported. An initial difference in practice between Europe and North America was over case-finding and treatment with some authorities in Europe using active case-finding, contact tracing and treatment/prophylaxis with antivirals to try and delay transmission. This article details the history of this practice in the past two months and explains how and why countries are moving to mitigation, especially treating with antivirals those at higher risk of experiencing severe disease.
欧洲经历了2009年甲型H1N1流感大流行的首次传播和爆发两个多月的时间。本文总结了迄今为止的一些经验,并展望了预计秋季将影响每个国家的流感活动增加情况。迄今为止,传播在国家之间和国家内部的分布极不均衡,其中英国经历的病例最多,传播率最高。大多数感染症状轻微,但需要住院治疗的人数在稳步增加,报告的死亡人数也在增多。欧洲和北美在病例发现和治疗方面最初存在差异,欧洲一些当局采用主动病例发现、接触者追踪以及使用抗病毒药物进行治疗/预防,试图延缓传播。本文详细介绍了过去两个月这种做法的历程,并解释了各国如何以及为何转向缓解措施,特别是对那些有严重疾病高风险的人群使用抗病毒药物进行治疗。